CSIMarket
 
Eloxx Pharmaceuticals Inc   (ELOX)
Other Ticker:  
 
 

Eloxx Pharmaceuticals Inc Cash flow Statement Quarterly

ELOX



Select the Financial Report:   Period:   Fiscal Year:



Cash flow Statement
(Quarterly, GAAP in millions $)

(Sep 30 2023)
9 Months
(Jun 30 2023)
6 Months
(Mar 31 2023)
3 Months
(Dec 31 2022)
12 Months
(Sep 30 2022)
9 Months
Income -14.16 - -6.23 -36.07 -29.75
Depreciation & amortization 0.04 - 0.02 0.08 0.07
Amortization of Other Assets 0.22 - 0.12 0.54 0.40
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense - - - - -
Impairment of Long-Lived Assets Held-for-use - - - 0.04 -
Provision for Loan, Lease, and Other Losses - - - - -
Inventories Decrease /-Increase - - - - -
Research and Development in Process - - - - -
Gain (Loss) on Disposition of Property Plant Equipment -0.26 - - - -
Share-based Compensation 1.63 - 0.60 3.02 2.38
Income (Loss) from Equity Method Investments - - - - -
Fair Value Adjustment of Warrants -0.27 - - - -
Deferred Rent - - - - -
Unrealized Gain Loss On Stock Rights - - - - -
Unrealized Gain Loss On Warrant Derivatives - - - - -
Noncash Or Part Noncash Acquisition Payables Assumed - - - - -
Non Cash Or Part Non Cash Acquisition Accrued Pay Roll - - - - -
Non Cash Or Part Non Cash Acquisition Accrued Expenses - - - - -
Non Cash Or Part Non Cash Acquisition Deferred Tax Liability - - - - -
Operating Lease Right Of Use Asset Amortization - - - - -
Amortization And Revaluation Of Discount In Respect To Convertible Loan - - - - -
Gain On Extinguishment Of Debt - - - - -
Gain On Extinguishment Of Paycheck Protection Program Debt - - - - -
Operating Lease Right Of Use Asset Amortization Expense 0.52 - -0.17 -0.45 -0.28
Change In Fair Value Of Derivative Liabilities 0.05 0.02 0.01 0.12 0.17
Increase Decrease In Operating Lease Liabilities -0.53 - - - -
Income taxes - - - - -
Losses/ -gains on Investments net - - - - -
Accounts Receivable - - - - -
Increase (Decrease) in Accounts Payable 0.13 - -0.59 1.64 0.22
Increase (Decrease) in Accrued Liabilities -0.36 - -0.57 -1.40 0.32
Deferred Revenue and Customer Advances and Deposits - - - - -
Increase (Decrease) in Prepaid Expense and Other Assets 0.03 - -0.58 0.25 0.06
Other Working Capital - - - - -
Other Noncash Items - - - - -
Other net - - - - -
Payments for (Proceeds from) Other Operating Activities 0.64 -0.02 0.58 0.62 0.45
Discontinued operations - - - - -
Net Cash flow from Operating Activities -12.33 - -6.81 -31.85 -26.18
Capital Expenditures - - - -0.07 -0.07
Sale of Capital Items 0.26 - 0.01 - -
Proceeds from Sale and Maturity of Marketable Securities - - - - -
Payments to Acquire Available-for-sale Securities, Debt - - - - -
Real Estate Investments - - - - -
Increase (Decrease) in Restricted Cash - - - - -
Payments for (Proceeds from) Loans - - - - -
Payments for (Proceeds from) Deposits - - - - -
Payments for (Proceeds from) Long-term Investments, Total - - - - -
Payments for (Proceeds from) Federal Reserve and Federal Home Loan Bank - - - - -
Cash Acquired from Acquisition - - - - -
Interest in Subsidiaries and Affiliates - - - - -
Sale of businesses - - - - -
Accounts payable - - - - -
Receivables - - - - -
Payments for (Proceeds from) Other Investing Activities - - - - -
Other Net - - - - -
Discontinued operations - - - - -
Net Cash flow from Investing Activities 0.26 - 0.01 -0.07 -0.07
Short-term debt Net - - - - -
Other borrowing transactions - - - - -
Long-term debt - borrowings - - - - -
Long-term debt - repayments -7.72 - -7.50 - -
Federal Home Loan Bank and Federal Funds - - - - -
Issuances/ -repurchases of Comm. Stock 3.15 1.43 - - -
Partnership and Parent Transactions - - - - -
Issuances/ -repurchases of Pref. Stock - - - - -
Deposits, Annuities, Contract Holders Funds - - - - -
Other financing activities net - - - - -
Other net -17.73 -1.43 -19.47 -42.57 -42.57
Proceeds From Government Grant - - - - -
Proceeds From Issuance Of Preferred Stock And Warrants Net - - - - -
Proceeds From Issuance Of Bridge Notes - - - - -
Debt Conversion Converted Instrument Amount - - - - -
Proceeds From Issuance Of Preferred Stock And Preference Stock Net - - - - -
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 19.47 - 19.47 42.57 42.57
Noncash Acquisition Of Treasury Shares - - - - -
Non Cash Issuance Of Shares Upon Exercise Of Warrants - - - - -
Fair Value Of Warrants Issued In Connection With Long Term Debt - - - - -
Non Cash Final Payment On Debt Financing Obligation - - - - -
Non Cash Deferred Public Offering Costs In Accounts Payable And Accruals - - - - -
Proceeds From Advances From Collaboration Partners 0.43 - - 8.50 7.00
Proceeds From Advances From Collaboration Partner - - - - -
Payments of Dividends, Preferred Stock and Preference Stock - - - - -
Dividends paid - - - - -
Net Cash flow from Financing Activities -2.40 - -7.50 8.81 8.50
Effect of exchange rate on cash flow - - - - -
Discontinued operations - - - - -
Free Cash Flow -12.07 - -6.80 -31.91 -26.25
Total Cash Flow -14.47 - -14.30 -23.10 -17.75
Cash & cash equiv. at beg. of the Year 4.78 4.33 4.90 19.21 24.55
Cash & cash equivalents at end of period - - - - -
Cash Interests paid - - - - -
Cash Income taxes paid - - - - -




Untitled Document





	
	


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com